OxSonics® Therapeutics’ proprietary platform technology, SonoTran®, is being developed to provide a step-change in the therapeutic index of anti-cancer agents without the development costs or delays associated with drug reformulation. SonoTran is designed to increase the dose and distribution of anti-cancer agents within solid tumours, therebyincreasing the efficacy and/or reducing the toxicity of these agents across the majority of the most challenging solid tumour cancers.The approach has been specifically designed to fit seamlessly into existing oncology clinical workflows, and has the major advantage of enabling healthcare professionals to see-as-they-treat by providing visualisation on-screen and in real time.The SonoTran drug delivery platform is based on ground-breaking technological advances, originally invented at the University of Oxford’s Institute of Biomedical Engineering.OxSonics is based in Oxford in the UK. For more information please visit: www.oxsonics.com.

Biotechnology

OxSonics Therapeutics

OxSonics Therapeutics' headquarters in Oxford, United Kingdom

Jérome Marzinski, MBA

Calum Crake

David Preston

Cliff Rowe

The Operations Team at OxSonics Therapeutics plays a critical role in ensuring the seamless execution of the SonoTran® platform's development and implementation. This team, composed of key leaders in development, regulatory affairs, quality assurance, and finance, coordinates cross-functional efforts to streamline clinical workflows, manage budgets, and ensure compliance. Their collaborative approach enables the effective advancement of innovative anti-cancer therapies while maintaining operational efficiency and maximizing therapeutic outcomes.

Operations Team

The Engineering Team at OxSonics Therapeutics is responsible for advancing and optimizing the SonoTran® platform through innovative engineering solutions. This team collaborates on the integration of cutting-edge hardware and software systems, ensuring real-time visualization and effective delivery of anti-cancer agents to solid tumors. Their work is pivotal in enhancing the efficacy and safety of cancer treatments, ultimately contributing to improved patient outcomes in oncology therapy.

Engineering Team

The Leadership Team at OxSonics Therapeutics is responsible for setting the strategic direction of the company, overseeing the development and commercialization of the SonoTran® platform. They collaborate to drive innovation, secure partnerships, and ensure effective execution of clinical strategies, while fostering a culture of excellence and accountability within the organization. Their vision and leadership are crucial for navigating the complex landscape of oncology and advancing the company's mission to improve treatment outcomes for patients with solid tumors.

OxSonics Therapeutics

Org chart

Teams

Operations Team

Engineering Team

Leadership Team

Offices

OxSonics Therapeutics

Org chart

Teams

Operations Team

Engineering Team

Leadership Team

Offices

Related companies